Adrenal Cancer: Clinical Trials

9 trials for Adrenal Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 recruiting, 2 unknown, 1 not yet recruiting. 2 Not applicable, 1 Early Phase 1, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Unknown 1
Early Phase 11Terminated 1
Phase 11Completed 1
Phase 21Recruiting 1

Follow Adrenal Cancer: new trials by email Literature Review of Adrenal Cancer trials Research Report on Adrenal Cancer

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Thyroid Health Outcomes Registry for Surgery
Thyroid Diseases, Thyroid Neoplasms
Not yet recruitingPirogov Russian National Research Medical University30002026-09-012026-09-10
Phase II Study of PD-1 Inhibitor Combined With Apatinib and Mitotane in the Treatment of Advanced Adrenal Cortical Carcinoma
Camrelizumab, Apatinib, mitotane - Adrenal Cortical Carcinoma, Adrenal Cortical Cancer
Phase 2RecruitingWest China Hospital282025-03-152025-06-03
Assessment of Metabolic Complications in Patients With Adrenal Tumors Through Radiological Images
Adrenal Cancer
RecruitingIRCCS Azienda Ospedaliero-Universitaria di Bologna10002025-01-012025-01-30
The Registry of Oncology Outcomes Associated With Testing and Treatment
Biomarker Testing (L), Systemic Treatment (T), Patient Reported Outcomes (P) - Adenocarcinoma, Adenocystic Carcinoma
CompletedTaproot Health1672021-05-052024-12-18
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
Cancer, All Types, Cancer of Liver
UnknownSpeciCare10002019-03-212020-12-04
Salivary Free Cortisol Response to Cosyntropin Stimulation Test in Mitotane Treated Patients
Cosyntropin stimulation test - Adrenal Insufficiency, Adrenal Cancer
Not applicableUnknownBnai Zion Medical Center502017-03-142019-01-18
Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma
ATR-101 - Adrenocortical Carcinoma, Adrenal Cancer
Phase 1CompletedMillendo Therapeutics, Inc.632013-08-132017-11-06
Stereotactic Body Radiation Therapy (SBRT) in Metastatic Non-small Cell Lung Cancer
stereotactic body radiation therapy - Non-Small-Cell Lung Carcinoma, Liver Cancer
Not applicableCompletedWake Forest University Health Sciences292010-08-012019-11-29
A Pilot Study of F-18 Paclitaxel (FPAC) PET for Evaluating Drug Delivery of Solid Tumors in Breast, Lung, Renal, and Adrenal Cancers
FPAC - Breast Cancer, Lung Cancer
Early Phase 1TerminatedNational Cancer Institute (NCI)62010-03-092019-12-17

Narrower conditions

Adrenal Gland Neoplasms (9)  ·  Lung Neoplasms (4)  ·  Breast Neoplasms (3)  ·  Kidney Neoplasms (3)  ·  Liver Neoplasms (3)  ·  Adrenocortical Carcinoma (2)  ·  Anus Neoplasms (2)  ·  Bile Duct Neoplasms (2)  ·  Bone Neoplasms (2)  ·  Brain Neoplasms (2)  ·  Carcinoma, Renal Cell (2)  ·  Cholangiocarcinoma (2)  ·  Colonic Neoplasms (2)  ·  Esophageal Neoplasms (2)  ·  Glioblastoma (2)

Broader conditions

Adrenal Gland Diseases (9)  ·  Endocrine Gland Neoplasms (9)  ·  Endocrine System Diseases (9)  ·  Neoplasms by Site (9)  ·  Neoplasms (7)  ·  Carcinoma (5)  ·  Neoplasms by Histologic Type (5)  ·  Neoplasms, Glandular and Epithelial (5)  ·  Adenocarcinoma (4)  ·  Lung Diseases (4)  ·  Pathologic Processes (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Respiratory Tract Diseases (4)  ·  Respiratory Tract Neoplasms (4)  ·  Thoracic Neoplasms (4)

Interventions

Biological Therapy (1)  ·  Drug Therapy (1)  ·  Immunotherapy (1)  ·  Mitotane (1)  ·  Molecular Diagnostic Techniques (1)  ·  N-(2,6-bis(1-methylethyl)phenyl)-N'-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride (1)  ·  Patient Reported Outcome Measures (1)  ·  Quality of Life (1)  ·  Radiosurgery (1)  ·  apatinib (1)  ·  camrelizumab (1)

Sponsors

Bnai Zion Medical Center (1)  ·  IRCCS Azienda Ospedaliero-Universitaria di Bologna (1)  ·  Millendo Therapeutics, Inc. (1)  ·  National Cancer Institute (NCI) (1)  ·  Pirogov Russian National Research Medical University (1)  ·  SpeciCare (1)  ·  Taproot Health (1)  ·  Wake Forest University Health Sciences (1)  ·  West China Hospital (1)

Countries

United States (5)  ·  China (1)  ·  Germany (1)  ·  Israel (1)  ·  Italy (1)

Top investigators

Guido Di Dalmazi, MD (1)  ·  Jennifer Johnson, MD, PhD (1)  ·  Karen A Kurdziel, M.D. (1)  ·  Ken Dixon, MD (1)  ·  Leonard Saiegh, MD (1)  ·  Raymond Bergan, MD (1)  ·  Razelle Kurzrock, MD (1)  ·  Vivek Subbiah, MD (1)  ·  William Blackstock, MD (1)

Results publications

PMID 26666256, PMID 29149611, PMID 30003996, PMID 31984451